Stockscreener 앱 받기
9.175
0.99%
0.075
전일 마감가:
$9.10
열려 있는:
$9.01
하루 거래량:
77,043
Relative Volume:
0.16
시가총액:
$563.84M
수익:
-
순이익/손실:
$-41.43M
주가수익비율:
-11.61
EPS:
-0.79
순현금흐름:
$-39.97M
1주 성능:
+1.10%
1개월 성능:
-26.48%
6개월 성능:
+10.72%
1년 성능:
-16.68%
1일 변동 폭
$8.663
$9.53
1주일 범위
$8.51
$9.53
52주 변동 폭
$6.00
$20.50
Gh Research Plc Stock (GHRS) Company Profile
GHRS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
GHRS
Gh Research Plc
|
9.175 | 563.84M | 0 | -41.43M | -39.97M | -0.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.09 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
559.01 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
594.73 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
230.31 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.84 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Gh Research Plc Stock (GHRS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-13 | 개시 | Guggenheim | Buy |
| 2025-03-07 | 개시 | RBC Capital Mkts | Outperform |
| 2025-02-13 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-08-16 | 개시 | H.C. Wainwright | Buy |
| 2022-06-16 | 개시 | ROTH Capital | Buy |
Gh Research Plc 주식(GHRS)의 최신 뉴스
What Will GH Research PLC (NASDAQ: GHRS) Be Like In 2025 - Stocksregister
(GHRS) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
(GHRS) Proactive Strategies - news.stocktradersdaily.com
How To Trade (GHRS) - news.stocktradersdaily.com
Guggenheim starts GH Research at Buy, sees long-term upside potential - Yahoo Finance
Guggenheim Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq
GH Research PLC (GHRS) Shares Rise Despite Market Challenges - The News Heater
How to Take Advantage of moves in (GHRS) - news.stocktradersdaily.com
GH Research (NASDAQ:GHRS) Earns Outperform Rating from Analysts at Royal Bank of Canada - Defense World
GH Research PLC (NASDAQ:GHRS) Receives $30.67 Consensus PT from Brokerages - Defense World
Q1 Earnings Forecast for GH Research Issued By HC Wainwright - Defense World
RBC Capital Initiates Coverage of GH Research (GHRS) with Outperform Recommendation - Nasdaq
FY2029 EPS Estimates for GH Research Lifted by HC Wainwright - Defense World
GH Research initiated with an Outperform at RBC Capital - TipRanks
GH Research PLC Reports 2024 Financial Results and Clinical Progress - TipRanks
H.C. Wainwright maintains $40 target on GH Research stock By Investing.com - Investing.com South Africa
H.C. Wainwright maintains $40 target on GH Research stock - Investing.com
Postpartum Depression Pipeline Revealed in 2025 Forecast Report Featuring GH Research, Reunion Neuroscience, Lipocine, and Brii Biosciences - GlobeNewswire Inc.
Why GH Research PLC (GHRS) is Skyrocketing So Far in 2025 - MSN
Why These 15 Biotech Stocks Are Skyrocketing So Far In 2025 - Insider Monkey
GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
GH Research (GHRS) to Release Quarterly Earnings on Thursday - MarketBeat
GH Research (NASDAQ:GHRS) Announces Quarterly Earnings Results - MarketBeat
H.C. Wainwright maintains buy on GH Research stock, $40 target - MSN
12 Best Psychedelic Stocks to Buy in 2025 - Insider Monkey
Psychedelic: GH Research, Compass Pathways report earnings results - Yahoo Finance
GH Research (NASDAQ:GHRS) Given New $32.00 Price Target at Stifel Nicolaus - MarketBeat
GH Research Reports Full Year 2024 Financial Results and Provides Business Updates - GlobeNewswire
Form F-3 GH Research PLC - StreetInsider.com
GH Research Reports 2024 Financial Results and Clinical Progress - TipRanks
Can GH Research's Depression Drug Change Treatment Paradigms? Phase 2b Shows Striking 57.5% Remission Rate - StockTitan
Stifel raises GH Research stock target to $32 on strong trial data - Investing.com
Stifel raises GH Research stock target to $32 on strong trial data By Investing.com - Investing.com South Africa
GH Research PLC (GHRS): Among the Best Performing Small Cap Stocks So Far In 2025 - Insider Monkey
Small-Cap Stocks Surge: GH Research, Society Pass and Reborn Coffee Lead Monday Gainers - HPBL
GHRS Stock Rallies 55% in a Week: Here's What You Should Know - MSN
Cantor Fitzgerald Forecasts GH Research FY2024 Earnings - Defense World
GH Research (NASDAQ:GHRS) Earns Overweight Rating from Analysts at Cantor Fitzgerald - MarketBeat
Cantor Fitzgerald Initiates Coverage of GH Research (GHRS) with Overweight Recommendation - MSN
Cantor Fitzgerald sets GH Research stock Overweight, $14 target By Investing.com - Investing.com Australia
Cantor Fitzgerald sets GH Research stock Overweight, $14 target - MSN
GH Research initiated with an Overweight at Cantor Fitzgerald - TipRanks
Gh Research Plc (GHRS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.77%
0.11%
자본화:
|
볼륨(24시간):